e.g. mhealth
Search Results (1 to 10 of 12 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 5 JMIR Cancer
- 5 JMIR Formative Research
- 2 Journal of Medical Internet Research
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Research Protocols
- 0 JMIR Human Factors
- 0 JMIR Medical Informatics
- 0 JMIR Public Health and Surveillance
- 0 JMIR mHealth and uHealth
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
In oncology, electronic patient-reported outcome (e PRO)–based monitoring has gained a great deal of interest in recent years. e PROs have been shown to improve quality of life (Qo L) and survival and reduce the number of unscheduled visits among patients receiving chemotherapy for advanced cancer [4-6].
JMIR Form Res 2025;9:e62749
Download Citation: END BibTex RIS
Electronic patient-reported outcome (e PRO) interventions have gained recognition as convenient and safe tools for promoting the early detection of symptoms and adverse events [4,5].
JMIR Cancer 2025;11:e53539
Download Citation: END BibTex RIS
Leveraging Patient-Reported Outcome Measures for Optimal Dose Selection in Early Phase Cancer Trials
Leveraging an electronic PRO (e PRO) solution, using a smartphone app, for example, would enable free-text symptom text to be resurfaced as a list of existing AEs to be easily rescored at future time points.
Approaches to simplify adverse event capture and scoring (A) using organ system grouping and (B) collecting the most bothersome adverse events associated with overall impact score.
JMIR Cancer 2025;11:e64611
Download Citation: END BibTex RIS
The aim of this study was to test the usability of using an e PRO system (Atom5) with individuals who had a TBI.
People who had a TBI were recruited in July 2021 from Headway UK, a UK-based charity aiming to promote understanding of all aspects of brain injury and provide information, support and services to survivors, their families and carers.
JMIR Form Res 2025;9:e58128
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
The historical e PRO data were recorded in the same manner using the earlier versions of the mobile app [11] and were therefore comparable to the prospective e PRO data.
This study was approved by the Swiss Institutional Review Board (KEK-ZH: 2021-D0051) and was conducted in accordance with the principles of the Declaration of Helsinki (current version). The study was also registered on Clinical Trials.gov (NCT05234021).
JMIR Cancer 2024;10:e54178
Download Citation: END BibTex RIS
Real-world studies have demonstrated that an e PRO can facilitate reporting of common treatment symptoms (eg, tiredness, fatigue, and anxiety) compared with standard medical records [6], and a separate study found population level benefit in patients with cancer, including improved 1-, 3-, and 5-year survival [7].
JMIR Cancer 2022;8(2):e29292
Download Citation: END BibTex RIS
Electronic patient-reported outcome (e PRO) systems for symptom monitoring of patients with cancer have had demonstrated quality of life and survival benefits in controlled trials (Table 1). They also result in a reduction of emergency hospitalization and have favorable cost-effectiveness and clinical utility; in addition, users have good perceptions of e PRO systems [1-9].
J Med Internet Res 2021;23(9):e30549
Download Citation: END BibTex RIS
There is growing interest in integrating electronic PRO (e PRO) into routine clinical practice during chemotherapeutic and immunotherapeutic interventions. Most cancer patients are motivated to spend time and effort documenting symptoms during their consultation for shared reporting with physicians. Patients’ self-empowerment and self-reporting should also improve patient-clinician communication, symptom detection, and symptom control [1].
J Med Internet Res 2021;23(8):e29271
Download Citation: END BibTex RIS
Approaches to systematic collection of data using e PRO systems have been shown to prompt clinical action for symptom management [21] and make care more patient centered [22].
JMIR Form Res 2020;4(11):e18982
Download Citation: END BibTex RIS